Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2017 / Cilt: 20 - Sayı: 3

The Success of Rehabilitation in a Case with Transformed Polyarticular Gout Disease After Antituberculosis Drugs: Case Report

Antitüberküloz İlaç Kullanımıyla Poliartiküler Forma Dönüşen Gut Vakasında Rehabilitasyonun Başarısı

Pages
150–154
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we report the case of a male patient with chronic gout, who had a acute gout episode during antituberculosis treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gout is characterized by hyperuricemia, recurrent attacks of acute arthritis and accumulation of monosodium urate crystals in the joints.
📊
Key Findings & Data:Obesity, hypertension, hyperlipidemia, alcohol, ingestion of drugs which elevate serum urate concentration, red meat and seafood are the risk factors for gout.
💡
Conclusion & Impact:In this article, we report the case of a male patient with chronic gout, who had a acute gout episode during antituberculosis treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gout is characterized by hyperuricemia, recurrent attacks of acute arthritis and accumulation of monosodium urate crystals in the joints. Clinical presentation of gout is important because of the work loss and caused disability. Obesity, hypertension, hyperlipidemia, alcohol, ingestion of drugs which elevate serum urate concentration, red meat and seafood are the risk factors for gout. The most common agents that can promote flares of gout are diuretics (thiazide and loop diuretics), salicylates, pyrazinamide, ethambutol. Lifestyle modifications, including weight loss, dietary changes, hypertension control, and medical treatment are important of gout treatment. At the same time benefits of rehabilitation program can not be ignored. In this article, we report the case of a male patient with chronic gout, who had a acute gout episode during antituberculosis treatment.

Özet

Gut hiperürisemi; tekrarlayıcı akut artrit atakları ile seyreden, eklemlerde monosodyum ürat kristallerinin biriktiği bir hastalıktır. Gut kliniği, iş gücü kaybı ve dizabiliteye sebep olması açısından önemlidir. Obezite, hipertansiyon, hiperlipidemi, alkol, kan ürik asit düzeyini yükselten ilaçlar, kırmızı et ve deniz ürünleri gut için risk faktörleridir. Gutu alevlendien en yaygın ilaçlar diüretikler (tiazid ve loop diüretikler), salisilatlar, pirazinamid ve etambutoldür. Kilo verme, diyet değişiklikleri, hipertansiyon kontrolü gibi yaşam tarzı düzenlemeleri ve medikal tedavi gut tedavisinde önemlidir. Bununla birlikte, rehabilitasyon programının yararları göz ardı edilemez. Burada antitüberküloz tedavi süresince gut atağı geçiren, kronik gutlu bir erkek olgu sunulmuştur.

🔖

Cite This Article

ŞAHİN-ONAT, Ş., KARACİF, D. Y., TÜRKBEY, T. A., DEMİR, S. Ö., ULAŞLI, A. M. (2017). The Success of Rehabilitation in a Case with Transformed Polyarticular Gout Disease After Antituberculosis Drugs: Case Report. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 20 - Sayı: 3, 150–154. https://ajindex.com/articles/166016

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wang W, Xu D, Wang B, Yan S, Wang X, Yin Y, et al. Increased risk of cancer in relation to gout: a review of three prospective cohort studies with 50,358 subjects. Mediators Inflamm 2015;2015:680853. Reuss-Borst MA. Hyperuricemia. When and how to treat? Internist (Berl) 2016;57(2):194- 201. Scirocco C, Rutigliano IM, Finucci A, Iagnocco A. Musculoskeletal ultrasonography in gout. Med Ultrason 2015;17(4):535-40. Turgay M. Kristal artropatiler. Düzgün N, editör. Romatoloji. Ankara: Pfizer İnflamasyon; 2011. p.282-9.
  2. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015;11(11):649-62.
  3. Pham AQ, Doan A, Andersen M. Pyrazinamide-induced hyperuricemia. P T 2014; 39(10):695-715.
  4. Gerdan V, Akkoc N, Ucan ES, Bulac Kir S. Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia. Singapore Med J 2013;54(6):e125-6. Postlethwaite AE, Bartel AG, Kelley WN. Hyperuricemia due to ethambutol. N Engl J Med 1972;286(14):761-2.
  5. Amodio MI, Bengualid V, Lowy FD. Development of acute gout secondary to pyrazinamide in a patient without a prior history of gout. DICP 1990;24(11):1115-6.
  6. Rao TP, Schmitt JK. Gout secondary to pyrazinamide and ethambutol. Va Med Q 1996; 123(4):271. Scott JT. Drug-induced gout. Baillieres Clin Rheumatol 1991;5(1):39-60.
  7. Rider TG, Jordan KM. The modern management of gout. Rheumatology (Oxford) 2010;49(1):5-14.
  8. Gutman AB, Yü TF, Berger L. Renal function in gout. 3. estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid). Am J Med 1969; 47(4):575-92.
  9. Sharma TN, Jain NK, Mathur BB, Nanawati V, Sharma GS, Sharma VK. Hyperuricemia and arthralgia during pyrazinamide therapy. Ind J Tub 1981;28(2):92-7.
  10. Gupta S, Gupta V, Kapoor B, Kapoor V. Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps. J Indian Med Assoc 2007;105(6):341-2.
  11. Tosun AK, Koca NT, Karataş GK. Acute gouty arthritis during pyrazinamide treatment: a case report. Mod Rheumatol 2004;14(4):306-8.
  12. Inoue T, Ikeda N, Kurusawa T, Sato A, Nakatani K, Ikeda T, et al. Hyperuricemia and arthralgia during pyrazinamide treatment. Nihon Kokyuki Gakkai Zasshi 1999;37(2):115- 8. Şişmanlar T, Aslan AT, Budakoğlu I. Is hyperuricemia overlooked when treating pediatric tuberculosis patients with pyrazinamide? J Trop Pediatr 2015;61(5):351-6.
  13. Öncel G, Öncel D. Dual energy dual source computed tomography technical principles and